Kelly D. Deck

2020

In 2020, Kelly D. Deck earned a total compensation of $579.5K as Chief Financial Officer at Inhibrx.

Compensation breakdown

Non-Equity Incentive Plan$41,419
Option Awards$282,894
Salary$252,000
Other$3,199
Total$579,512

Deck received $282.9K in option awards, accounting for 49% of the total pay in 2020.

Deck also received $41.4K in non-equity incentive plan, $252K in salary and $3.2K in other compensation.

Rankings

In 2020, Kelly D. Deck's compensation ranked 10,602nd out of 13,090 executives tracked by ExecPay. In other words, Deck earned more than 19.0% of executives.

ClassificationRankingPercentile
All
10,602
out of 13,090
19th
Division
Manufacturing
4,544
out of 5,624
19th
Major group
Chemicals And Allied Products
1,889
out of 2,257
16th
Industry group
Drugs
1,655
out of 1,957
15th
Industry
Biological Products, Except Diagnostic Substances
375
out of 411
9th
Source: SEC filing on April 13, 2022.

Deck's colleagues

We found three more compensation records of executives who worked with Kelly D. Deck at Inhibrx in 2020.

2020

Klaus Wagner

Inhibrx

Chief Medical Officer

2020

Mark Lappe

Inhibrx

Chief Executive Officer

2020

Brendan Eckelman

Inhibrx

Chief Scientific Officer

News

You may also like